ScoopUpdates reports that a Wichita mental health provider offers FDA-approved Spravato nasal spray and ketamine infusions for treatment-resistant depression and PTSD.
ScoopUpdates describes treatment offerings in Wichita
ScoopUpdates reports that a Wichita mental health provider offers FDA-approved Spravato nasal spray and ketamine infusions. The source says these services are offered for treatment-resistant depression and PTSD. ScoopUpdates characterizes the provider’s approach as an advancement in mental health care.
The supplied ScoopUpdates extract identifies Spravato as a nasal spray and states that it is FDA-approved. The extract also states that ketamine infusions are available through the Wichita provider. It does not provide further information about availability, eligibility, pricing, insurance coverage, referral requirements, appointment timing, or treatment duration.
Personalized protocols and testing
According to ScoopUpdates, the Wichita provider combines its medical offerings with personalized protocols. The source also says the provider uses pharmacogenomic testing as part of its approach.
ScoopUpdates states that these protocols and testing are intended to optimize patient outcomes. The extract does not describe what the personalized protocols include, how pharmacogenomic testing is used, or which patients may be offered either service. It also does not report clinical results, patient experiences, or comparisons with other approaches.
Conditions named in the source
The ScoopUpdates extract specifically names treatment-resistant depression and PTSD in connection with the provider’s Spravato nasal spray and ketamine infusion offerings. The source does not define treatment-resistant depression or provide details about how either condition is assessed.
The extract also does not say whether the services are available to all patients with the listed conditions. It provides no information about age groups, medical screening, follow-up care, or whether treatment is offered in person only. ScoopUpdates does not report whether other mental health services are part of the provider’s care model.
What the source does and does not establish
ScoopUpdates presents the Wichita provider’s offerings as a combination of medical treatments, personalized protocols, and pharmacogenomic testing. The source’s description is limited to those stated offerings and its characterization of their purpose.
The supplied extract does not include independent evidence supporting the source’s characterization, and it does not provide outcome data. It also does not state whether these offerings have changed recently or whether they are available elsewhere in Kansas.
What this means for Kansas patients
For people looking for treatment locally, this report points to Spravato and ketamine infusion services described by ScoopUpdates in Wichita. The directory lists 37 published clinics in Kansas and can help patients identify local treatment listings.
This is general information, not medical advice.
More Kansas reporting on treatment updates.
This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.